Growth Metrics

Volitionrx (VNRX) Capital Expenditures (2016 - 2025)

Volitionrx filings provide 9 years of Capital Expenditures readings, the most recent being $10967.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 84.89% to $10967.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $89558.0, a 67.73% decrease, with the full-year FY2025 number at $89558.0, down 67.73% from a year prior.
  • Capital Expenditures hit $10967.0 in Q4 2025 for Volitionrx, down from $76783.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $775027.0 in Q3 2023 to a low of -$775027.0 in Q4 2023.
  • Median Capital Expenditures over the past 5 years was $128572.0 (2021), compared with a mean of $171223.4.
  • Biggest five-year swings in Capital Expenditures: soared 350.14% in 2022 and later tumbled 233.91% in 2023.
  • Volitionrx's Capital Expenditures stood at $128572.0 in 2021, then soared by 350.14% to $578752.0 in 2022, then tumbled by 233.91% to -$775027.0 in 2023, then surged by 109.37% to $72601.0 in 2024, then tumbled by 84.89% to $10967.0 in 2025.
  • The last three reported values for Capital Expenditures were $10967.0 (Q4 2025), $76783.0 (Q2 2025), and $1808.0 (Q1 2025) per Business Quant data.